RecruitingNot ApplicableNCT03869996

Total Knee Arthroplasty: Fast Track Protocol is the Future?

Randomised Controlled Study Comparing Fast Track and Standard Care Protocol on the Functional Outcomes and Hospital Stay of Total Knee Arthroplasty


Sponsor

Istituto Ortopedico Rizzoli

Enrollment

64 participants

Start Date

Feb 25, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Fast-track total knee arthroplasty (TKA) is a well-established concept including optimized logistics and evidence-based treatment, focusing on minimizing surgical stress and improved post-operative recovery. The aim of this protocol is to compare the standard care and fast track total knee arthroplasties in terms of functional and subjective outcomes, hospital staying, number of transfusions and analgesic consumption.


Eligibility

Min Age: 18 YearsMax Age: 78 Years

Inclusion Criteria7

  • patients affected by knee osteoarthritis, eligible for primary total knee arthroplasty
  • BMI \< 32
  • Time up ang go test \</= 12 seconds
  • American Society of Anesthesiologists physical status classification system (ASA) \</= 2
  • preoperative hemoglobin (HB) \>13 g/dl
  • patients eligible for spinal anesthesia
  • presence of a care-giver

Exclusion Criteria4

  • psychiatric diseases
  • preoperative use of crutches
  • ASA \> 3
  • preoperative HB \< 13 g/dl

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREfast track care protocol

fast track care consists in educational preoperative preparation for patients, particular strategies for controlling pain and bleeding and intensive early rehabilitation protocol.

PROCEDUREstandard care protocol

standard care protocol consists in the same surgical intervention without educational preoperative preparation for patients and intensive early rehabilitation protocol.


Locations(1)

Istituto Ortopedico Rizzli

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03869996


Related Trials